A combination of glycosylated hemoglobin, impaired fasting glucose and waist circumference is effective in screening for individuals at risk for future type 2 diabetes

Abdul-Ghani, 2006, Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose, Diabetes Care, 29, 1130, 10.2337/dc05-2179 ADA (American Diabetes Association), 2003, Clinical practice recommendations, standards of medical care for patients with diabetes mellitus, Diabetes Care, 26, S33, 10.2337/diacare.26.2007.S33 ADA (American Diabetes Association), 2005, Standards of medical care in diabetes, Diabetes Care, 28, S4, 10.2337/diacare.28.suppl_1.S4 ADA (American Diabetes Association), 2007, Diagnosis and classification of diabetes mellitus, Diabetes Care, 30, S42, 10.2337/dc07-S042 Adams, 2005, Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition, Diabetes Care, 28, 2777, 10.2337/diacare.28.11.2777 ADVANCE, 2008. The largest ever study of diabetes shows intensive glucose control reduces serious complications. San Francisco, USA. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183 Anonymous, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Balkau, 2007, International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries, Circulation, 116, 1942, 10.1161/CIRCULATIONAHA.106.676379 Bays, 2007, The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys, Int. J. Clin. Pract., 61, 737, 10.1111/j.1742-1241.2007.01336.x Beckett, 2008, Treatment of hypertension in patients 80 years of age or older, N. Engl. J. Med., 358, 1887, 10.1056/NEJMoa0801369 Buse, 2007, Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods, Am. J. Cardiol., 99, 21i, 10.1016/j.amjcard.2007.03.003 Cauchi, 2006, Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes, Diabetes, 55, 2903, 10.2337/db06-0474 Cauchi, 2007, No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects, Diabetologia, 50, 214, 10.1007/s00125-006-0505-z Chandak, 2007, Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population, Diabetologia, 50, 63, 10.1007/s00125-006-0502-2 Chen, 1999, High prevalence of impaired fasting glucose and type 2 diabetes mellitus in Penghu Islets, Taiwan: evidence of a rapidly emerging epidemic?, Diabetes Res. Clin. Pract., 44, 59, 10.1016/S0168-8227(99)00025-X Coutinho, 1999, The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years, Diabetes Care, 22, 233, 10.2337/diacare.22.2.233 2003, Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?, Diabetes Care, 26, 688, 10.2337/diacare.26.3.688 Despres, 2006, Abdominal obesity and metabolic syndrome, Nature, 444, 881, 10.1038/nature05488 Dunstan, 2002, The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study, Diabetes Care, 25, 829, 10.2337/diacare.25.5.829 Florenz, 2006, TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program, N. Engl. J. Med., 355, 241, 10.1056/NEJMoa062418 Grant, 2006, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes, Nat. Genet., 38, 320, 10.1038/ng1732 Humphries, 2006, Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women, J. Mol. Med., 84, 1005, 10.1007/s00109-006-0108-7 IDF (International Diabetes Federation), 2005. Consensus worldwide definition of the metabolic syndrome. <www.idf.org/metabolic_syndrome>. 1997, Prevalence of chronic diseases in older Italians: comparing self reported and clinical diagnosis, Int. J. Epidemiol., 26, 995, 10.1093/ije/26.5.995 Ko, 2004, Effects of obesity on the conversion from normal glucose tolerance to diabetes in Hong Kong Chinese, Obes. Res., 12, 889, 10.1038/oby.2004.108 Kosaka, 2005, Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males, Diabetes Res. Clin. Pract., 67, 152, 10.1016/j.diabres.2004.06.010 Lenti, G., Pellegrini, A., Pagano, G., 1970. Moderni aspetti fisiopatologici e clinici della malattia diabetica. 71° Congr. S.I.M.I. (in Italian). Liao, 2001, Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose, Diabetes Care, 24, 39, 10.2337/diacare.24.1.39 Maggi, S., Romanato, G., 2008. Epidemiologia della sindrome metabolica nell’an-ziano. Sindr. Metab. Mal. Cardiovasc. 1, 22 (in Italian). Maggi, 1994, The Italian Longitudinal Study on Aging (ILSA): design and methods, Aging Clin. Exp. Res., 6, 464, 10.1007/BF03324279 Motta, L., Carnazzo, G., 1994. Il diabete nell’anziano, 95° Congr. S.I.M.I. Florence. Motta, 2006, Diabetes mellitus in the elderly: diagnostic features, Arch. Gerontol. Geriatr., 42, 101, 10.1016/j.archger.2005.05.001 Motta, M., Bennati, E., Cardillo, E., Passamonte, M., Ferlito, L., Malaguarnera, M., 2008a. The metabolic syndrome (MS) in the elderly: Considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modifications. Arch. Gerontol. Geriatr. doi:10.1016/j.archger.-2008.03.005. Motta, 2008, Pathogenesis of the senile diabetes, Indian J. Med. Res., 128, 225 Motta, M., Bennati, E., Cardillo, E., Ferlito, L., Malaguarnera, M., 2009. The value glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly. Arch. Gerontol. Geriatr. Apr 1 [Epub ahead of print]. National Heart, Lung, and Blood Institute, 2008. ACCORD telebriefing prepared remarks, February 6. Norberg, 2006, A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type2 diabetes: OGTT is not needed, J. Intern. Med., 260, 263, 10.1111/j.1365-2796.2006.01689.x Ramachandran, 2006, The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subiects with impaired glucose tolerance (IDPP-1), Diabetologia, 49, 289, 10.1007/s00125-005-0097-z Sargeant, 2002, Predicting incident diabetes in Jamaica: the role of anthropometry, Obes. Res., 10, 792, 10.1038/oby.2002.107 Satman, 2002, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP), Diabetes Care, 25, 1551, 10.2337/diacare.25.9.1551 Saxena, 2006, Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals, Diabetes, 55, 2890, 10.2337/db06-0381 Schmidt, 2005, Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study, Diabetes Care, 28, 2013, 10.2337/diacare.28.8.2013 Schulze, 2006, Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study, Diabetes Care, 29, 1921, 10.2337/dc06-0895 Shaw, 1999, Impaired fasting glucose or impaired glucose tolerance. what best predicts future diabetes in Mauritius?, Diabetes Care, 22, 399, 10.2337/diacare.22.3.399 Smith, 2006, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute, Circulation, 113, 2363, 10.1161/CIRCULATIONAHA.106.174516 Thorwaldsen, 1995, Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardio-vascular Disease, Stroke, 26, 361, 10.1161/01.STR.26.3.361 Tulloch-Reid, 2003, Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians, Diabetes Care, 26, 2556, 10.2337/diacare.26.9.2556 Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N. Engl. J. Med., 344, 1343, 10.1056/NEJM200105033441801 Twigg, 2007, Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association, Med. J. Aust., 186, 461, 10.5694/j.1326-5377.2007.tb00998.x US Department of Health and Human Services, 2002. American Diabetes Association. HHS, ADA warns Americans of “pre-diabetes”. Press release. DHHS, Washington, DC. Vaccaro, 2005, Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition, Diabetes Care, 28, 1786, 10.2337/diacare.28.7.1786 WHO (World Health Organization), 1999 Wood, 1998, Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention, Atherosclerosis, 140, 199, 10.1016/S0021-9150(98)90209-X Zeggini, 2007, TCF7L2: the biggest story in diabetes genetics since HLA?, Diabetologia, 50, 1, 10.1007/s00125-006-0507-x Zeggini, 2008, Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, Nat. Genet., 40, 638, 10.1038/ng.120 Zhang, 2006, Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U:S. women and men, Diabetes, 55, 2645, 10.2337/db06-0643